Pulmonary embolism: Difference between revisions
Kashish Goel (talk | contribs) |
Kashish Goel (talk | contribs) |
||
| Line 41: | Line 41: | ||
==Treatment== | ==Treatment== | ||
===[[Pulmonary embolism treatment algorithm|Treatment Approach]]=== | |||
===[[Pulmonary embolism medical therapy|Medical Therapy]]:=== | |||
:*'''Anticoagulation:''' [[Heparin]] | [[Low molecular weight heparin]] | [[Pulmonary embolism medical therapy#Direct Xa inhibitor|Factor Xa inhibitor]] | [[Warfarin]] | :*'''Anticoagulation:''' [[Heparin]] | [[Low molecular weight heparin]] | [[Pulmonary embolism medical therapy#Direct Xa inhibitor|Factor Xa inhibitor]] | [[Warfarin]] | ||
| Line 48: | Line 48: | ||
:*'''Fibrinolytic:''' [[Pulmonary embolism treatment thrombolysis|Thrombolysis]] | :*'''Fibrinolytic:''' [[Pulmonary embolism treatment thrombolysis|Thrombolysis]] | ||
===[[Pulmonary embolism surgery|Surgery]]:==== | |||
:*[[Pulmonary thrombectomy|Catheter-Based Interventions]] | [[Pulmonary thrombectomy|Surgical Embolectomy]] | [[Inferior vena cava filter|Inferior Vena Cava Filters]] | [[Thromboreductive Strategies]] | [[Pulmonary embolism angioplasty|Percutaneous Transluminal Venous Angioplasty and Stent Placement]] | [[Pulmonary thromboendarterectomy|Pulmonary Endarterectomy]] | :*[[Pulmonary thrombectomy|Catheter-Based Interventions]] | [[Pulmonary thrombectomy|Surgical Embolectomy]] | [[Inferior vena cava filter|Inferior Vena Cava Filters]] | [[Thromboreductive Strategies]] | [[Pulmonary embolism angioplasty|Percutaneous Transluminal Venous Angioplasty and Stent Placement]] | [[Pulmonary thromboendarterectomy|Pulmonary Endarterectomy]] | ||
Revision as of 17:17, 8 May 2012
For patient information click here
| Pulmonary embolism | |
| ICD-10 | I26 |
|---|---|
| ICD-9 | 415.1 |
| DiseasesDB | 10956 |
| MedlinePlus | 000132 |
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism On the Web |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Classification Scheme
I: Acute pulmonary embolism | Chronic pulmonary embolism
II: Massive pulmonary embolism | Submassive pulmonary embolism | Low-risk pulmonary embolism
Pathophysiology
Epidemiology and Demographics
Risk factors
Natural History, Complications & Prognosis
Differential Diagnosis
Pretest probability of PE
Wells Score | Original Geneva Score | Revised Geneva Score | Simplified Geneva Score | PE Rule-out Criteria | Summary of PE Clinical Probability based on Clinical Prediction Rules | ESC Guideline Recommendations
Diagnosis
History & Symptoms | Physical Examination | Laboratory Tests | Arterial Blood Gas | D-dimer | Biomarkers | Electrocardiogram | Chest x ray | Ventilation/Perfusion scan | Echocardiography | Compression Ultrasonography | Chest CT | CT Pulmonary Angiography (CTPA) | MRI
Treatment
Treatment Approach
Medical Therapy:
- Anticoagulation: Heparin | Low molecular weight heparin | Factor Xa inhibitor | Warfarin
- Fibrinolytic: Thrombolysis
Surgery:=
Guidelines
ACC/AHA Guidelines
Guidelines for Initial Anticoagulation for Acute PE | Surgical embolectomy | Inferior vena cava filters | Iliofemoral DVT management guidelines | Compression therapy for DVT | Thromboreductive Strategies | Percutaneous Transluminal Venous Angioplasty and Stent Placement
ESC Guidelines
- Diagnosis: Suspected high-risk PE | Suspected non-high-risk PE | Low clinical probability | Intermediate clinical probability | High clinical probability
- Treatment: High-risk pulmonary embolism | Non-high-risk pulmonary embolism | Long-term treatment | Inferior vena cava filters | Thrombolysis
Discharge Care
Discharge Care | Follow-Up/Recurrence | Support group